Ticker Scorecard - HRTX Basics Company: Heron Therapeutics, Inc. IPO Date: January 23, 2014 Sector: Healthcare Industry: Biotech Market Cap: $240.31M Activated in VL: True Average Daily Range Avg Daily Range: $0.40 | 3.07% Avg Daily Range (30 D): $0.07 | 4.39% Avg Daily Range (90 D): $0.06 | 3.50% Institutional Daily Volume Avg Daily Volume: 1.22M Avg Daily Volume (30 D): 3.81M Avg Daily Volume (90 D): 2.37M Trade Size Avg Trade Size (Sh.): 155 Avg Trade Size (Sh.) (30 D): 285 Avg Trade Size (Sh.) (90 D): 269 Institutional Trades Total Inst.Trades: 3,398 Avg Inst. Trade: $1.58M Avg Inst. Trade (30 D): $1.14M Avg Inst. Trade (90 D): $2.03M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.03M Avg Closing Trade (30 D): $.7M Avg Closing Trade (90 D): $4.5M Avg Closing Volume: 175.9K     News Oct 29, 2024 @ 8:05 PM Heron Therapeutics to Report Third Quarter 2024 Fi... Source: Prnewswire Sep 17, 2024 @ 10:00 AM Chemotherapy Induced Nausea and Vomiting Treatment... Source: Fact.Mr Jul 2, 2024 @ 12:43 PM Merck (MRK) Gets Exclusive Rights to Opevesostat F... Source: Zacks Equity Research Jul 1, 2024 @ 2:31 PM FDA Rejects Rocket's (RCKT) Gene Therapy BLA for R... Source: Zacks Equity Research Jun 27, 2024 @ 3:03 PM FDA Expands AbbVie's (ABBV) Epkinly Label in Folli... Source: Zacks Equity Research Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.03 $-.06 $-.02 Diluted EPS $-.03 $-.06 $-.02 Revenue $ 32.81M $ 36.02M $ 34.67M Gross Profit $ 23.35M $ 25.51M $ 26.23M Net Income / Loss $ -4.85M $ -9.24M $ -3.16M Operating Income / Loss $ -4.46M $ -6.45M $ -4.8M Cost of Revenue $ 9.46M $ 10.52M $ 8.44M Net Cash Flow $ 7.36M $ -2.06M $ -8.23M PE Ratio     Splits Jan 13, 2014:   20:1 May 25, 2007:   4:1